ZYUS Life Sciences Announces Closing of First Tranche of Unit Offering

ZYUS Life Sciences Announces Closing of First Tranche of Unit Offering

SASKATOON, Saskatchewan -- ZYUS Life Sciences Corporation (the “Company”) (TSX-V: ZYUS), a Canadian-based life sciences company focused on the development and commercialization of novel cannabinoid-based pharmaceutical drug candidates for pain management, is pleased to announce that it has now completed a first tranche (the "First Tranche") of its non-brokered private placement (the "Offering") of units of the Company (each a "Unit") previously …